- Trials with a EudraCT protocol (45)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (971)
45 result(s) found for: cts.
Displaying page 1 of 3.
EudraCT Number: 2020-003959-16 | Sponsor Protocol Number: CAAA405A12301 | Start Date*: 2021-04-27 | |||||||||||
Sponsor Name:Novartis Pharma AG | |||||||||||||
Full Title: Phase III study for evaluation of the diagnostic performance of [18F]CTT1057 PET imaging in patients with prostate cancer with rising PSA levels [biochemical recurrence (BCR)] (GuidePath) | |||||||||||||
Medical condition: Prostate cancer with rising PSA levels [biochemical recurrence (BCR)] | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: FR (Completed) ES (Ongoing) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-001871-31 | Sponsor Protocol Number: 4076 | Start Date*: 2008-09-04 | ||||||||||||||||
Sponsor Name:Region skåne- Hässleholms sjukvårdsorganisation | ||||||||||||||||||
Full Title: Local steroid injection in the treatment of idiopathic carpal tunnel syndrome: A randomized double-blind placebo-controlled trial among patients planned for surgical treatment | ||||||||||||||||||
Medical condition: Neurography verified Carpal tunnel syndrome | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: SE (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-001435-48 | Sponsor Protocol Number: 464/11 | Start Date*: 2013-06-05 | |||||||||||||||||||||
Sponsor Name:Keele University | |||||||||||||||||||||||
Full Title: The clinical and cost effectiveness of a steroid injection versus a night splint for Carpal Tunnel Syndrome: a pragmatic randomised trial in primary care | |||||||||||||||||||||||
Medical condition: Carpal Tunnel Syndrome (CTS) | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: GB (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2014-003272-23 | Sponsor Protocol Number: NUBE | Start Date*: 2014-10-24 | |||||||||||
Sponsor Name:Dr. Jordi Montero Homs- Unidad de Neuromuscular- Servicio de Neurología- Hospital Universitario de Bellvitge | |||||||||||||
Full Title: Prospective Pilot Study of the treatment of compression of median nerve neuropathy with Nucleo CMP Forte®. | |||||||||||||
Medical condition: Carpal Tunnel Syndrome (CTS) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-000873-56 | Sponsor Protocol Number: CARPA2013 | Start Date*: 2013-07-04 | |||||||||||
Sponsor Name:Federico Diaz González | |||||||||||||
Full Title: Randomized, two paralel groups, open clinical trial stratified by severity to stimate the cost-effectivity of surgical vs corticosteroid injection treatment on carpal tunnel syndrome | |||||||||||||
Medical condition: Carpal tunnel syndrome | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-002289-62 | Sponsor Protocol Number: ST200-SSMA-14-001 | Start Date*: 2014-09-11 | |||||||||||
Sponsor Name:SIGMA-TAU, Industrie Farmaceutiche Riunite S.p.A. | |||||||||||||
Full Title: Electroneurographic and clinical evaluation in patients with mild / moderate Carpal Tunnel Syndrome , following conservative pharmacological treatment with Nicetile®. | |||||||||||||
Medical condition: Carpal Tunnel Syndrome | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-006048-29 | Sponsor Protocol Number: INjECT | Start Date*: 2022-02-21 | ||||||||||||||||
Sponsor Name:AOU MATERDOMINI | ||||||||||||||||||
Full Title: BotulInum toxin type A for peripheral Neuropathic pain in subjEcts with Carpal Tunnel syndrome: a multicenter, randomized, double-blind, placebo-controlled study | ||||||||||||||||||
Medical condition: Peripheral neuropathic pain in subjects with carpal tunnel syndrome | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: IT (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-001072-21 | Sponsor Protocol Number: MKN106762 | Start Date*: 2006-08-08 |
Sponsor Name:GlaxoSmithKline Research and Development Ltd | ||
Full Title: A double-blind placebo-controlled study of the efficacy and safety of the P38 Map Kinase inhibitor SB681323 in patients with neuropathic pain following nerve trauma | ||
Medical condition: Neuropathic pain | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2007-006515-23 | Sponsor Protocol Number: STC- Progesterone -2007 | Start Date*: 2008-01-02 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA SENESE | |||||||||||||
Full Title: Randomized clinical trial for the local therapy of carpal tunnel syndrome: cortisone vs progesterone | |||||||||||||
Medical condition: - mild-to-moderate idiopathic carpal tunnel syndrome | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-003214-13 | Sponsor Protocol Number: I4X-MC-JFCL | Start Date*: 2013-07-19 | |||||||||||
Sponsor Name:Eli Lilly and Company | |||||||||||||
Full Title: A Randomized, Multicenter, Open-Label, Phase 2 Study of Paclitaxel-Carboplatin Chemotherapy Plus Necitumumab (IMC-11F8) Versus Paclitaxel-Carboplatin Chemotherapy Alone in the First-Line Treatme... | |||||||||||||
Medical condition: Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-003694-34 | Sponsor Protocol Number: 2-HIT | Start Date*: 2017-10-25 | ||||||||||||||||
Sponsor Name:Ziekenhuis Oost-Limburg | ||||||||||||||||||
Full Title: Onset and duration of Forearm nerve blockade performed with a single distal injection versus sequential injections at distal and proximal locations alongside the nerves: a blinded randomized contro... | ||||||||||||||||||
Medical condition: Dupuytren contrature and Carpal Tunnel syndrome | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: BE (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-002640-70 | Sponsor Protocol Number: 20-HMedIdeS-19 | Start Date*: 2022-04-13 | |||||||||||
Sponsor Name:Hansa Biopharma AB | |||||||||||||
Full Title: A controlled, open-label post-authorisation efficacy and safety study in imlifidase desensitised kidney transplant patients with positive crossmatch against a deceased donor prior to imlifidase tre... | |||||||||||||
Medical condition: | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Trial now transitioned) DE (Trial now transitioned) ES (Ongoing) AT (Trial now transitioned) BE (Trial now transitioned) FR (Trial now transitioned) NL (Trial now transitioned) IT (Trial now transitioned) SI (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-000639-16 | Sponsor Protocol Number: 9090-09 | Start Date*: 2012-10-17 | ||||||||||||||||
Sponsor Name:Synta Pharmaceuticals Corp | ||||||||||||||||||
Full Title: A Single Arm, Phase 2 Study of Ganetespib in Subjects with Advanced Non- Small-Cell Lung Cancer with Anaplastic Lymphoma Kinase Gene Rearrangement (ALK-Positive NSCLC) | ||||||||||||||||||
Medical condition: AKL positive advanced non-small cell lung cancer | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Completed) ES (Temporarily Halted) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2021-004756-42 | Sponsor Protocol Number: DIA2021-08 | Start Date*: 2022-01-25 | |||||||||||||||||||||
Sponsor Name:Diakonhjemmet sykehus | |||||||||||||||||||||||
Full Title: The NOR-CACTUS Trial: A NORwegian trial CompAring treatment strategies for Carpal TUnnel Syndrome | |||||||||||||||||||||||
Medical condition: Carpal tunnel syndrome - median neuropathy caused by nerve entrapment at the site of the carpal tunnel in the wrist | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: NO (Trial now transitioned) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-003201-96 | Sponsor Protocol Number: I4X-MC-JFCK | Start Date*: 2013-03-13 | |||||||||||
Sponsor Name:Eli Lilly and Company | |||||||||||||
Full Title: A Single-Arm, Multicenter, Open-Label, Phase 2 Study of Gemcitabine-Cisplatin Chemotherapy Plus Necitumumab (IMC-11F8) in the First-Line Treatment of Patients With Stage IV Squamous Non-Small Ce... | |||||||||||||
Medical condition: Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-000050-10 | Sponsor Protocol Number: FORMaT001 | Start Date*: 2023-01-02 | |||||||||||
Sponsor Name:University of Queensland | |||||||||||||
Full Title: Finding the Optimal Regimen for Mycobacterium abscessus Treatment | |||||||||||||
Medical condition: Mycobacterium abscessus pulmonary disease | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-006493-23 | Sponsor Protocol Number: NIMAO/2021-1/YG-01 | Start Date*: 2022-04-04 | ||||||||||||||||||||||||||
Sponsor Name:Nimes University Hospital | ||||||||||||||||||||||||||||
Full Title: Evaluation of the patient postoperative experience of two modes of WALANT-type anesthesia (lidocaine alone or combined with ropivacaine) used in ambulatory upper-extremity surgery | ||||||||||||||||||||||||||||
Medical condition: | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: FR (Completed) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-002755-15 | Sponsor Protocol Number: GM-IMAB-002-01 | Start Date*: 2014-01-28 | ||||||||||||||||
Sponsor Name:Ganymed Pharmaceuticals AG | ||||||||||||||||||
Full Title: A first-in-human dose escalation and dose finding phase I/II trial of IMAB027 in patients with recurrent advanced ovarian cancer | ||||||||||||||||||
Medical condition: recurrent advanced ovarian cancer | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Female | |||||||||||||||||
Trial protocol: BE (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2012-005477-31 | Sponsor Protocol Number: I4C-MC-JTBC | Start Date*: 2013-08-27 | |||||||||||
Sponsor Name:Eli Lilly and Company | |||||||||||||
Full Title: A Randomized, Open-Label Phase 2 Study Evaluating LY2875358 Plus Erlotinib and LY2875358 Monotherapy in MET Diagnostic Positive NSCLC Patients with Acquired Resistance to Erlotinib | |||||||||||||
Medical condition: Non Small Cell Lung Cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) IT (Completed) GB (Completed) BE (Completed) ES (Completed) NL (Completed) FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-005487-22 | Sponsor Protocol Number: A2A-005 | Start Date*: 2022-12-21 | |||||||||||
Sponsor Name:iTeos Belgium SA | |||||||||||||
Full Title: A randomized, double-blind, placebo-controlled, Phase 2 study evaluating efficacy and safety of inupadenant in combination with carboplatin and pemetrexed in adults with nonsquamous non-small cell ... | |||||||||||||
Medical condition: Nonsquamous non-small cell lung cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Trial now transitioned) BE (Trial now transitioned) ES (Ongoing) PL (Completed) DE (Ongoing) IT (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
